ClinConnect ClinConnect Logo
Search / Trial NCT07039487

EVALUATION OF NEUTROPHIL FLUORESCENCE IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH SEPTIC SHOCK

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Jun 17, 2025

Trial Information

Current as of June 28, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help diagnose a serious condition called disseminated intravascular coagulation (DIC) that can happen in patients with septic shock—a life-threatening response to infection. The researchers are looking at whether measuring a special glow (called fluorescence) in certain white blood cells (neutrophils) can reliably and quickly detect DIC. Their goal is to find the right level of this glow that correctly identifies at least 90% of patients with this condition, which could help doctors diagnose and treat it sooner.

Adults 18 years and older who are in the intensive care unit with septic shock may be eligible to participate, as long as they don’t have certain other health issues like severe liver disease, very low white blood cell counts, or are pregnant or breastfeeding. Patients need to be able to give consent, or if they can’t, a family member may provide it, or emergency procedures may be used if no family is available. Participants can expect tests that measure neutrophil fluorescence, which is a blood test, to help the researchers understand if this method works well. This study is not yet recruiting, but it aims to improve early diagnosis of DIC in very sick patients, potentially leading to better care.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female ≥ 18 years of age
  • Patient admitted to intensive care for septic shock
  • Patient affiliated to a social security scheme or entitled to it
  • Non-opposition by the patient or a relative in the event that the patient is not in a state to express his or her consent or inclusion in an emergency procedure in the event that the patient is not in a state to express his or her opinion and no relative of the patient can be reached.
  • Exclusion Criteria:
  • Dying patient on the day of inclusion
  • Cirrhosis Child Pugh C
  • Neutropenia (\<500 mm3)
  • Patient under judicial protection
  • Patient under guardianship or curatorship
  • Pregnancy
  • Breastfeeding

About University Hospital, Strasbourg, France

The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.

Locations

Strasbourg, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported